semaglutide ckd approval Long-term kidney outcomes of in obesity and cardiovascular disease in the SELECT trial FDA has approved Ozempic (semaglutide)

Ibuprofen, as a non-steroidal anti-inflammatory drug (NSAID), can irritate the stomach lining and increase the risk of gastric ulcers, especially with prolonged use

Types of rashes that can occur with semaglutide include erythema (redness), urticaria (hives), and pruritus (itchiness)

Users weaning off tirzepatide or managing semaglutide withdrawal should expect dry mouth to gradually improve as tissue levels decrease

Clinical evidence provides clear guidance on what to expect and when

[26] [11] Patients should be counseled to report symptoms such as neck mass, dysphagia, or persistent hoarseness for prompt evaluation